EndoQuest Robotics announced today that it received FDA investigational device exemption (IDE) for a study of its surgical ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/91.IM06wodO.js ...

Wood joins AssetMark with over two decades of experience leading financial planning teams and building innovative solutions across a range of disciplines, including trust and estate, tax planning, ...

EndoQuest will commence its PARADIGM clinical trial for endoluminal robotic colorectal surgery at five leading US hospitals ...

The suspected madman behind a deadly stabbing spree in Manhattan Monday has a long criminal history — and had just walked free from Rikers Island a month before the terrifying attacks, The Post ...

EndoQuest Robotics , a privately held medical device company and pioneer in the development of flexible endoluminal robotic technologies, has submitted an Investigational Device Exemption (IDE ...

EndoQuest Robotics Inc. has submitted an Investigational Device Exemption, or IDE, application for its pivotal colorectal clinical study. With its flexible robotic system, the privately held medical ...

Novel scar-free robotic technology may define a new standard in minimally invasive surgery. EndoQuest's novel scar-free robotic technology may define a new standard in minimally invasive surgery.

Houston, TX, Nov. 14, 2024 (GLOBE NEWSWIRE) -- EndoQuest Robotics, Inc., a privately held medical device company and pioneer in the development of flexible endoluminal robotic technologies ...

Novel scar-free robotic technology may define a new standard in minimally invasive surgery. EndoQuest's novel scar-free robotic technology may define a new standard in minimally invasive surgery. By ...